Lung Cancer Highlights from ASCO 2005

Lung Cancer Highlights from ASCO 2005 Ornella Belvedere, Francesco Grossi Oncologist 2006; 11: 39-50 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in lung cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Discuss the results of recent trials on the addition of a molecularly targeted agent to standard first-line chemotherapy in NSCLC. Explain the role of surgery in the treatment of stage III NSCLC. Discuss the current status of adjuvant chemotherapy in NSCLC. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Jan. 09, 2006 Most Recent Review: May 8, 2007* Most Recent Update: Jan. 09, 2006 Date Credit Expires: Jan. 09, 2008 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.